Augmedix, Inc. (AUGX) Tops Q2 EPS by 1c

Augmedix, Inc. (NASDAQ: AUGX) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $10.78 million versus the consensus estimate of $10.37 million.

For earnings history and earnings-related data on Augmedix, Inc. (AUGX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15